PT1225890E - Rivastigmina para o tratamento de doencas oculares - Google Patents
Rivastigmina para o tratamento de doencas ocularesInfo
- Publication number
- PT1225890E PT1225890E PT00992430T PT00992430T PT1225890E PT 1225890 E PT1225890 E PT 1225890E PT 00992430 T PT00992430 T PT 00992430T PT 00992430 T PT00992430 T PT 00992430T PT 1225890 E PT1225890 E PT 1225890E
- Authority
- PT
- Portugal
- Prior art keywords
- rivastigmine
- treatment
- eye diseases
- diseases
- eye
- Prior art date
Links
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 title 1
- 208000030533 eye disease Diseases 0.000 title 1
- 229960004136 rivastigmine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99120678 | 1999-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1225890E true PT1225890E (pt) | 2005-05-31 |
Family
ID=8239225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00992430T PT1225890E (pt) | 1999-10-19 | 2000-10-17 | Rivastigmina para o tratamento de doencas oculares |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6534541B1 (enExample) |
| EP (1) | EP1225890B1 (enExample) |
| JP (1) | JP2003512324A (enExample) |
| AR (1) | AR026062A1 (enExample) |
| AT (1) | ATE285764T1 (enExample) |
| AU (1) | AU766001B2 (enExample) |
| CA (1) | CA2384690C (enExample) |
| DE (1) | DE60017174T2 (enExample) |
| DK (1) | DK1225890T3 (enExample) |
| ES (1) | ES2234708T3 (enExample) |
| NZ (1) | NZ518164A (enExample) |
| PT (1) | PT1225890E (enExample) |
| WO (1) | WO2001028553A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2237163T3 (es) | 1998-10-01 | 2005-07-16 | Novartis Ag | Nuevas formulaciones orales de revastigmina de liberacion controlada. |
| US9993558B2 (en) | 2004-10-01 | 2018-06-12 | Ramscor, Inc. | Sustained release eye drop formulations |
| US8541413B2 (en) * | 2004-10-01 | 2013-09-24 | Ramscor, Inc. | Sustained release eye drop formulations |
| WO2009022345A1 (en) * | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
| CN107417574B (zh) * | 2017-03-21 | 2019-12-03 | 浙江省医学科学院 | 2,4-双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL74497A (en) | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| HU201906B (en) * | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
| US4900748A (en) | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
| JP3708957B2 (ja) | 1991-09-26 | 2005-10-19 | アメリカ合衆国 | （−）−エゼロリン、（−）−ｎ１−ノルエゼロリンおよび（−）−ｎ１−ベンジルノルエゼロリンの置換フェンゼリンおよびフェニルカルバミン酸塩：特異的アセチルコリンエステラーゼ阻害薬としての使用 |
| ES2206449T3 (es) | 1991-09-26 | 2004-05-16 | The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services | Inhibidores de colinesterasas, composiciones farmaceuticas y sus usos. |
| AU1138097A (en) * | 1995-12-22 | 1997-07-17 | Alcon Laboratories, Inc. | Combinations of prostaglandins and miotics for lowering intraocular pressure |
-
2000
- 2000-10-11 US US09/686,025 patent/US6534541B1/en not_active Expired - Fee Related
- 2000-10-17 ES ES00992430T patent/ES2234708T3/es not_active Expired - Lifetime
- 2000-10-17 PT PT00992430T patent/PT1225890E/pt unknown
- 2000-10-17 EP EP00992430A patent/EP1225890B1/en not_active Expired - Lifetime
- 2000-10-17 AU AU28349/01A patent/AU766001B2/en not_active Ceased
- 2000-10-17 JP JP2001531383A patent/JP2003512324A/ja active Pending
- 2000-10-17 DE DE60017174T patent/DE60017174T2/de not_active Expired - Lifetime
- 2000-10-17 AR ARP000105450A patent/AR026062A1/es unknown
- 2000-10-17 AT AT00992430T patent/ATE285764T1/de active
- 2000-10-17 WO PCT/EP2000/010234 patent/WO2001028553A1/en not_active Ceased
- 2000-10-17 NZ NZ518164A patent/NZ518164A/en not_active IP Right Cessation
- 2000-10-17 DK DK00992430T patent/DK1225890T3/da active
- 2000-10-17 CA CA2384690A patent/CA2384690C/en not_active Expired - Fee Related
-
2003
- 2003-01-23 US US10/349,718 patent/US6835748B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2234708T3 (es) | 2005-07-01 |
| US6835748B2 (en) | 2004-12-28 |
| JP2003512324A (ja) | 2003-04-02 |
| AR026062A1 (es) | 2002-12-26 |
| NZ518164A (en) | 2003-10-31 |
| EP1225890B1 (en) | 2004-12-29 |
| DK1225890T3 (da) | 2005-04-04 |
| WO2001028553A1 (en) | 2001-04-26 |
| DE60017174T2 (de) | 2005-12-22 |
| US20030119832A1 (en) | 2003-06-26 |
| US6534541B1 (en) | 2003-03-18 |
| AU2834901A (en) | 2001-04-30 |
| CA2384690C (en) | 2010-08-17 |
| DE60017174D1 (de) | 2005-02-03 |
| ATE285764T1 (de) | 2005-01-15 |
| EP1225890A1 (en) | 2002-07-31 |
| AU766001B2 (en) | 2003-10-09 |
| CA2384690A1 (en) | 2001-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04156B1 (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
| EE200300214A (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
| PL367311A1 (en) | Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease | |
| PT1223927E (pt) | Utilizacao de retigabina para o tratamento de dores neuropaticas | |
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| PT1147083E (pt) | Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao | |
| AR028285A1 (es) | Medicamentos intracorporeos para tratamiento fotodinamico de enfermedad | |
| PT1392292E (pt) | Piranoindazoles e sua utilizacao para o tratamento de glaucoma | |
| FI20000863A0 (fi) | Uusi hoitomenetelmä | |
| PT1411926E (pt) | Inibidores de integrina para o tratamento de doencas oftalmicas | |
| PT1206436E (pt) | Retinoides para o tratamento de enfisema | |
| PT1154777E (pt) | Medicamento para o tratamento de hipertensao arterial | |
| NO20005179D0 (no) | Medikament behandling | |
| PT1321135E (pt) | Composicao para o tigimento de oxidacao das fibras ceratinicas | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
| PT983275E (pt) | Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes | |
| NO20033804L (no) | Karbamatforbindelser for behandling av smerte | |
| PT1286986E (pt) | Derivados de quinolil-piperidin-4-ilideno-metil-benzamida para o tratamento da dor | |
| PT1225890E (pt) | Rivastigmina para o tratamento de doencas oculares | |
| PT1220858E (pt) | Oxazinoquinolonas uteis para o tratamento de infeccoes virais | |
| PT1268482E (pt) | Piranoindois para o tratamento de glaucoma | |
| PT1135134E (pt) | Utilizacao de estimuladores do factor neurotrofico para o tratamento de doencas oftalmicas neurodegenerativas | |
| PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
| NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer |